U.S. Gynecology Robotic Surgery Market to Exhibit 6.8% CAGR till 2027; Rising Entrance of Prominent Manufacturers in the U.S. to Aid Growth

The U.S. gynecology robotic surgery market size is projected to reach USD 1.38 billion by 2027. The high demand for minimally invasive gynecology robotic surgery in the U.S. backed by the increasing improvements and launch of such products is set to boost growth in the near future. Fortune Business Insights™ provided this information in a new report, titled, “U.S. Gynecology Robotic Surgery Market Size, Share & COVID-19 Impact Analysis, By Type (Robotic Systems, Instruments and Accessories, and Services), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Physician’s Offices), and Regional Forecast, 2020-2027.” The report further mentions that the market stood at USD 1.04 billion in 2019. But, it is set to exhibit a CAGR of 6.8% during the forecast period between 2020 to 2027.

Titan Medical Signs Agreement with Medtronic to Develop Robotic Surgical Technologies

In June 2020, Titan Medical Inc., a medical device company based in Canada, entered into a development and license agreement with Medtronic plc, a Dublin-based medical device company. The main aim behind this agreement is to develop robotic assisted surgical technologies that would be used by both companies in the future. Titan is likely to receive a series of payments worth USD 31 million for the latter’s license to innovative technologies.

As per a company official, “These agreements will enable Titan to continue developing its single-port robotic surgical technologies by sharing its technologies and expertise with Medtronic. This would help Titan to bring in new single-port surgical options to the market.”

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/u-s-gynecology-robotic-surgery-market-103891

High Demand for Minimally Invasive Hysterectomies to Drive Growth

Nowadays, several prominent providers of gynecology robotic surgery, such as CMR surgical and Titan Medical Inc., are planning to enter the U.S. market by introducing unique products associated with gynecology robotic surgery. As the demand for minimally invasive hysterectomies is rising nowadays, these companies are increasing their research & development activities to compete in the market. This factor is set to boost the U.S. gynecology robotic surgery market growth in the coming years. However, the COVID-19 pandemic is set to decline growth by postponing or cancelling all the non-essential and elective procedures, including gynecology robotic surgeries.

Key Companies Aim to Surge Sales by Co-developing Novel Products  

The market in the U.S. is highly fragmented with the presence of numerous renowned companies. Most of them are partnering up or are collaborating with other key players to co-develop new products for gynecology robotic surgeries. Intuitive Surgical, Inc. is considered to be the leading company because of its development of da Vinci gynecologic procedures.

Fortune Business Insights™ presents a list of all the reputed gynecology robotic surgery providers operating in the U.S. They are as follows:

• Intuitive Surgical, Inc. (California, U.S.)
• TransEnterix Surgical, Inc. (North Carolina, U.S.)
• Medrobotics Corporation (Massachusetts, U.S.)
• Titan Medical Inc. (Ontario, Canada)
• CMR Surgical Limited   (Cambridge, U.K.)
• avateramedical GmbH (Jena, Germany)
• Medtronic (Dublin, Ireland)
• Verb Surgical, Inc. (California, U.S.)
• Olympus Corporation (Tokyo, Japan)
• Stryker (Michigan, U.S.)

Few Significant Industry Development-

• January 2018: Medrobotics Corp. bagged the U.S. FDA approval for marketing the Flex Robotic System. It will be used for robot-assisted visualization in thoracic, gynecological, and general surgical procedures in the U.S.
• October 2017: TransEnterix, Inc. received the U.S. FDA 510(k) clearance for its innovative Senhance Ultrasonic System. It will help the company to expand the attractiveness of digital laparoscopy and the Senhance platform for surgeons in the U.S.

Further Report Findings-

• Based on product, the instruments and accessories segment held 57.2% in terms of the U.S. gynecology robotic surgery market share in 2019. It is anticipated to dominate throughout the forthcoming years on account of the higher adoption of gynecology robotic surgery. Besides, the rising number of hysterectomies in the U.S. would propel growth.
• In terms of end-user, the ambulatory surgical centers segment is expected to hold the maximum share of the U.S. market for gynecology robotic surgery in the near future. This growth is attributable to the increasing technological advancements. In addition to this, the increasing inclination of people towards outpatient settings from inpatient settings is set to drive growth of this segment.

The market for gynecology robotic surgery in the U.S. can be segmented in the following way: